関連する実験動画
Updated: Feb 19, 2026

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
10.0K
シスプラチン誘発性オト毒性におけるエンドカンナビノイド信号伝達経路の解明
Sakthimala Palaniappan1, Annamaria Tisi1, Camilla Di Meo1
1Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
まとめ
シスプラチン化学療法は聴覚障害を引き起こす. この研究は,エンドカンナビノイド系を明らかにしています.
科学分野:
- オート・ニューロサイエンス
- 化学療法による副作用
- エンドカンナビノイド系の研究
背景:
- シスプラチン化学療法は,耳の毒性を引き起こし,不可逆的な聴力喪失につながる可能性があります.
- 現在,シスプラチン誘発の耳中毒性に対する効果的な治療法は存在しない.
- 聴覚機能におけるエンドカンナビノイド系 (ECS) の役割は,ほとんど未知のものです.
研究 の 目的:
- シスプラチン誘発のオト毒性におけるエンドカンナビノイドシステムの関与を調査する.
- 化学療法による聴覚障害を軽減するために,ECS内の潜在的な治療標的を特定する.
主な方法:
- 聴覚毛細胞のようなUB/OC1細胞におけるECSの分子プロファイリング.
- シスプラチンによって誘発されたオート毒性のインビトロモデルの確立.
- シスプラチン誘発性オト毒性のインビボモデルでの発見の検証.
- SR144528.8.を使用したカンナビノイド受容体2 (CB2R) の薬理学的阻害
主要な成果:
- 受容体や主要なエンドカンナビノイドを含むECSは,聴覚毛細胞に存在します.
- シスプラチン治療は,ECSの重要な成分 (CB2R,DAGLβ,ABHD6) を低下させ,毛細胞損傷を引き起こした.
- CB2Rの薬理学的阻害は,カスパース-3を阻害することによってシスプラチン誘発の毛細胞損傷から保護されます.
- In vivo試験では,in vitroの発見が確認され,CB2Rの耳毒性における生理学的関連性が強調されました.
結論:
- エンドカンナビノイドシステムの選択的要素は,シスプラチン誘発のオト毒性に関与しています.
- カナビノイド受容体2 (CB2R) は,化学療法による聴覚障害において重要な役割を果たします.
- CB2Rをターゲットにすることは,シスプラチン誘発の耳中毒性を予防または治療するための潜在的な治療戦略です.
関連する概念動画
Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
806
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
806
Intracellular Signaling Cascades
53.8K
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
655
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
655
Diversity in Cell Signaling Responses
8.0K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
8.0K
Opioid Receptors: Overview
4.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.9K

